Navigation Links
Bayer HealthCare's MEDRAD Interventional Business Announces Five-Year Data of Cotavance® Drug Eluting Balloon with Paccocath® Technology to be Presented at 2011 TCT
Date:11/3/2011

WARRENDALE, Pa., Nov. 3, 2011 /PRNewswire/ -- MEDRAD Interventional, a business of Bayer HealthCare, today announced that five-year data from the THUNDER trial will be presented at the 2011 Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation, in San Francisco. The data will focus on five-year rates of target lesion revascularization comparing the Cotavance® drug eluting balloon (DEB) catheter with Paccocath® Technology to standard balloon angioplasty (POBA) in popliteal arteries of patients with peripheral arterial disease (PAD). Presented by Prof. Dr. med. Thomas Zeller of Herz-Zentrum, Bad Krozingen, Germany, during the TCT-sponsored symposium, "Drug-Coated Balloons: Clinical Data and Applications," at 2 p.m. PST Nov. 10, the results will continue to build on the long-term clinical experience with the Paccocath® technology, which is available in Europe, but not yet approved in the U.S.

"The only published positive long-term clinical results to date with drug-eluting balloons have used MEDRAD's Paccocath technology, and these new data will now provide additional information out to five years, the longest time studied among DEBs," said Jack Darby, Senior Vice President of MEDRAD Interventional. "We remain committed to further elucidating long-term clinical outcomes with the Cotavance paclitaxel eluting balloon catheter compared to or in combination with other interventional therapies through our large clinical studies and registry program. Collectively, this will include more than 1,700 patients and approximately 200 centers around the world."

MEDRAD Interventional will have an extensive presence at the 2011 TCT conference. In addition to the presentation of new five-year data, MEDRAD is supporting two symposia, Management of Thrombus in STEMI Interventions: Discussion and Debate on the Role of AngioJet Thrombectomy and Manual Aspiration (Wednesday, Nov.
'/>"/>

SOURCE MEDRAD Interventional
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
2. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
3. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
4. Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress
5. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
6. Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
7. FDA Approves Bayer HealthCares Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A
8. Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology
9. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
10. Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting
11. Bayer Announces New Data on Novel Anti-cancer Compound BAY 73-4506
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... August 28, 2015 The scientific team ... with one of the leading academics in the field of ... record holder in life extension for model animals - 10 ... of aging and age-related diseases, primarily, around the stability and ... just been published as "Stability analysis of a model gene ...
(Date:8/28/2015)... Aug. 28, 2015  Perrigo Company plc ("Perrigo") (NYSE: ... completed the acquisition of leading OTC brands from GSK ... The transaction is a clear demonstration of Perrigo,s unique ... European distribution network spanning 36 countries.  ... commented, "We are excited to complete this transaction, ...
(Date:8/28/2015)... Aug. 28, 2015 , Joint ... Ra from Biostar , Published in ,Stem Cells ... of lifespan through multiple IV administration of Adipose-derived MSC ... life expectancy found , Commercialization within 5 years ... the possibility that adult mesenchymal stem cells (MSCs) may ...
Breaking Medicine Technology:Gero: Physics Meets Biology to Help Defeat Aging 2Gero: Physics Meets Biology to Help Defeat Aging 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4Korean Researchers Find the Possibility that Adult Mesenchymal Stem Cells (MSCs) May Extend Lifespan 2
... Wash., April 23 Archus Orthopedics, Inc.,announced today ... implant,of its TFAS-C(TM) system, the newest addition to ... condition in which degenerative changes in,the facet joints ... in the legs. Traditionally, patients with moderate to,severe ...
... LOUISVILLE, Colo., April 23 Replidyne, Inc.,(Nasdaq: ... enrollment in a,placebo-controlled Phase III clinical trial testing ... chronic bronchitis,(AECB). Replidyne took this action to conserve ... strategic transactions and maintaining,its research programs., The ...
Cached Medicine Technology:First Human Implant of New Archus Orthopedics Facet Replacement System 2Replidyne Discontinues Phase III Trial 2Replidyne Discontinues Phase III Trial 3
(Date:8/30/2015)... , ... August 30, 2015 , ... Natural Rest contains ... effects as sleep aids and calming remedies, which help to improve mood disorders and ... a great deal of research in the field of regenerative medicine conducted by Dr. ...
(Date:8/30/2015)... ... 30, 2015 , ... Nutritional Products International ( http://www.nutricompany.com ) ... Assistant to CEO Mitch Gould for Nutritional Products International. Through all methods ... Kathleen graduated from Florida State University with a Bachelor of Science in Business ...
(Date:8/29/2015)... ... 30, 2015 , ... On September 30, 2015, the Career and Transfer Center ... accredited Maricopa Community Colleges , will be hosting a Job Expo to provide ... and opportunities. , The Expo has expanded to much more than just a typical ...
(Date:8/29/2015)... ... August 29, 2015 , ... "I have ... Miller Place, N.Y. "I specialize in manual therapy, and my invention will provide ... be used for additional muscle dysfunction throughout the body." , They developed THE ...
(Date:8/29/2015)... ... 2015 , ... Dr. Tim Novelli, DC., Founder and President of the Patriot ... of the chiropractic field in the military. All too often VA hospitals treat patients ... made available to the VA program over a decade ago, the reality is that ...
Breaking Medicine News(10 mins):Health News:Creative Medical Health’s Natural Rest® Now Available on ReCreative Medical Health’s Natural Rest® Now Available on RevNutrition.com 2Health News:NPI Appoints New Executive Assistant To CEO 2Health News:Estrella Mountain Community College Expo Offers ‘One-Stop’ for Employers and Students Seeking Internships, Jobs, Careers and Service Learning Opportunities 2Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2Health News:The Patriot Project brings Chiropractic Care to the Armed Forces and their Families - Rapid Release Technology Joins the Effort to Recruit more Doctors to Pledge 2
... for Patients, Nurse Staffing and Cost Savings , ... introduced today by Sen. Al Franken (D-Minn.) will not only ... other health care facilities, but also will ensure patients get ... safest way possible, all while improving the bottom line for ...
... Subaru of America is joining the San Francisco Hep B ... the use of a 2010 Subaru Legacy detailed with full ... to "B a Hero" in preventing liver cancer and the ... ) , Hepatitis B causes up to 80 percent ...
... Austin City Limits music festival concluded, spa professionals from ... for the 19th annual International SPA Association Conference & ... participated in educational sessions, learned about the newest products ... Conference theme, "Simplify," resonated with attendees as they discussed ...
... Oct. 15 Hematopoietic stem cell transplantation (HSCT) and ... invasive fungal infections (IFIs). IFIs are a significant cause ... in the epidemiology of IFIs have led to an ... of which are linked to poor outcomes in patients. ...
... King of Prussia location to support Breast Cancer Awareness , ... a whole new twist. Nordstrom,s Department Store and non-profit ... to "bedazzle" their bras. Entries will be on display in ... PA on Saturday, October 17th from 11 a.m. until 5 p.m. ...
... -- Mayo Clinic clinicians and designers, along with ... a tool to involve patients more in their ... set of decision aid cards, could help patients ... to better outcomes. The results of this randomized ...
Cached Medicine News:Health News:Nation's RNs Hail Sen. Franken's Support for Safe Patient Handling Measure 2Health News:Subaru Donates 'Hep B Hero Mobile' to Support Campaign 2Health News:Subaru Donates 'Hep B Hero Mobile' to Support Campaign 3Health News:2009 ISPA Conference & Expo Rocks Out With Lance Armstrong in Austin 2Health News:Invasive Fungal Infections in HSCT Recipients: Improving Outcomes Through Prevention and Treatment 2Health News:Bedazzled Bras Benefit Breastcancer.org 2Health News:Mayo Clinic clinicians develop new decision aid tool to help type 2 diabetes patients 2Health News:Mayo Clinic clinicians develop new decision aid tool to help type 2 diabetes patients 3
Custom-made chisels....
9 inch sharp bone hook with grip handle....
Designed for proximal femoral elevation in total hip replacement or in other surgery with a similar need for bone manipulation....
Straight, single action bone forceps to excise, trim and sculpt bone....
Medicine Products: